<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Negative effects on the progression of <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> by <z:e sem="disease" ids="C0020459" disease_type="Disease or Syndrome" abbrv="">hyperinsulinaemia</z:e> and the insulin analogue glargine (A21Gly,B31Arg,B32Arg human insulin) have recently been suggested </plain></SENT>
<SENT sid="1" pm="."><plain>Most actions of this insulin analogue have hitherto been explained by direct stimulation of growth potential of neoplastic cells and by its IGF-1 related properties </plain></SENT>
<SENT sid="2" pm="."><plain>However, insulin-stimulated <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> could be an additional factor involved in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e> and clinical outcomes associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Five types of human <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (breast, colon, pancreas, lung and kidney) were evaluated for the presence of insulin receptors (IRs) on angiogenic structures </plain></SENT>
<SENT sid="4" pm="."><plain>In an in vitro <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> assay, various commercially available insulin compounds were evaluated for their potential to increase capillary-like tube formation of human microvascular endothelial cells (hMVEC) </plain></SENT>
<SENT sid="5" pm="."><plain>Insulin compounds used were: human insulin, insulin lispro (B28Lys,B29Pro human insulin), insulin glargine and insulin detemir (B29Lys[e-<z:chebi fb="0" ids="25456">tetradecanoyl</z:chebi>],desB30 human insulin) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Insulin receptors were found to be strongly expressed on the endothelium of microvessels in <z:hpo ids='HP_0000001'>all</z:hpo> evaluated <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, in addition to variable expression on <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>Low or no detectable expression of IRs was seen on microvessels in extratumoral stroma </plain></SENT>
<SENT sid="8" pm="."><plain>Incubation with commercially available insulin compounds increased capillary-like tube formation of hMVEC in vitro </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: Our results suggest that <z:hpo ids='HP_0000001'>all</z:hpo> tested insulin compounds may stimulate <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> by enhancing local <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>Future studies need to confirm the association between insulin therapy in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumour progression</z:e> </plain></SENT>
</text></document>